FDA Inspection 1281125 - Boehringer Ingelheim Pharmaceuticals, Inc. - September 11, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on September 11, 2025, issued by the New England District Office, covering human drugs.

Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Inspection Date: September 11, 2025
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · 9c62d459-d5fc-4614-8d41-987968509962

Violation Codes1

21 CFR 312.50

Full citation text and observation details available on the Dashboard.